194 related articles for article (PubMed ID: 7814531)
41. Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods.
Pfaller MA; Watanabe N; Castanheira M; Messer SA; Jones RN
J Antimicrob Chemother; 2011 Nov; 66(11):2581-4. PubMed ID: 21873291
[TBL] [Abstract][Full Text] [Related]
42. Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents.
Alexander BD; Byrne TC; Smith KL; Hanson KE; Anstrom KJ; Perfect JR; Reller LB
J Clin Microbiol; 2007 Mar; 45(3):698-706. PubMed ID: 17202279
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of 80% inhibition standards for the determination of fluconazole minimum inhibitory concentrations in three laboratories.
Espinel-Ingroff A; Steele-Moore L; Galgiani JN
Diagn Microbiol Infect Dis; 1994 Oct; 20(2):81-6. PubMed ID: 7867309
[TBL] [Abstract][Full Text] [Related]
44. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
Tan GL; Peterson EM
J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
[TBL] [Abstract][Full Text] [Related]
45. Comparative evaluation of a new commercial colorimetric microdilution assay (SensiQuattro Candida EU) with MIC test strip and EUCAST broth microdilution methods for susceptibility testing of invasive Candida isolates.
Koehling HL; Willinger B; Buer J; Rath PM; Steinmann J
J Clin Microbiol; 2015 Jan; 53(1):255-61. PubMed ID: 25392352
[TBL] [Abstract][Full Text] [Related]
46. Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870.
Pfaller MA; Messer SA; Coffmann S
J Clin Microbiol; 1995 May; 33(5):1094-7. PubMed ID: 7615712
[TBL] [Abstract][Full Text] [Related]
47. Use of a colorimetric system for yeast susceptibility testing.
Tiballi RN; He X; Zarins LT; Revankar SG; Kauffman CA
J Clin Microbiol; 1995 Apr; 33(4):915-7. PubMed ID: 7790460
[TBL] [Abstract][Full Text] [Related]
48. Posaconazole susceptibility testing against Candida species: comparison of broth microdilution and E-test methods.
Sóczó G; Kardos G; McNicholas PM; Falusi E; Gergely L; Majoros L
Mycoses; 2007 May; 50(3):178-82. PubMed ID: 17472612
[TBL] [Abstract][Full Text] [Related]
49. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
Linares MJ; Charriel G; Solís F; Casal M
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
[TBL] [Abstract][Full Text] [Related]
50. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Pfaller MA; Messer SA; Bolmström A; Odds FC; Rex JH
J Clin Microbiol; 1996 Jul; 34(7):1691-3. PubMed ID: 8784571
[TBL] [Abstract][Full Text] [Related]
51. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans.
Arthington-Skaggs BA; Jradi H; Desai T; Morrison CJ
J Clin Microbiol; 1999 Oct; 37(10):3332-7. PubMed ID: 10488201
[TBL] [Abstract][Full Text] [Related]
52. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
[TBL] [Abstract][Full Text] [Related]
53. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
Lee SC; Lo HJ; Fung CP; Lee N; See LC
J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
[TBL] [Abstract][Full Text] [Related]
54. [In vitro susceptibility testing of Candida species against fluconazole using the microdilution test with Alamar Blue].
Schröder G; Bernhardt H; Schulz K
Mycoses; 1996; 39 Suppl 2():17-21. PubMed ID: 9198739
[TBL] [Abstract][Full Text] [Related]
55. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
Yüksekkaya S; Fındık D; Arslan U
Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
[TBL] [Abstract][Full Text] [Related]
56. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
[TBL] [Abstract][Full Text] [Related]
57. Antifungal susceptibility testing of Candida albicans by flow cytometry.
Gökahmetoglu S; Nedret Koç A; Patiroglu T
Mycoses; 2003 Sep; 46(8):307-11. PubMed ID: 12950899
[TBL] [Abstract][Full Text] [Related]
58. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
Rex JH; Pfaller MA; Barry AL; Nelson PW; Webb CD
Antimicrob Agents Chemother; 1995 Jan; 39(1):40-4. PubMed ID: 7695326
[TBL] [Abstract][Full Text] [Related]
59. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
60. Cross-resistance phenotypes of fluconazole-resistant Candida species: results with 655 clinical isolates with different methods.
Stevens DA; Stevens JA
Diagn Microbiol Infect Dis; 1996; 26(3-4):145-8. PubMed ID: 9078451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
